Articles from Glancy Prongay & Murray LLP

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of EchoStar Corporation (“EchoStar” or the “Company”) (NASDAQ: SATS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming July 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired DoubleVerify Holdings, Inc. (“DoubleVerify” or the “Company”) (NYSE: DV) common stock between November 10, 2023 and February 27, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP reminds investors of the upcoming July 28, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Red Cat Holdings, Inc. (“Red Cat” or the “Company”) (NASDAQ: RCAT) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the District of New Jersey, captioned Cockrell v. UroGen Pharma Ltd., et al., Case No. 3:25-cv-06088, on behalf of persons and entities that purchased or otherwise acquired UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired DoubleVerify Holdings, Inc. (“DoubleVerify” or the “Company”) (NYSE: DV) common stock between November 10, 2023 and February 27, 2025, inclusive (the “Class Period”). DoubleVerify investors have until July 21, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of New Fortress Energy Inc. (“New Fortress” or the “Company”) (NASDAQ: NFE) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming July 15, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired MicroStrategy Incorporated d/b/a Strategy (“Strategy” or the “Company”) (NASDAQ: MSTR) securities between April 30, 2024 and April 4, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of DoubleVerify Holdings, Inc. (“DoubleVerify” or the “Company”) (NYSE: DV) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired MicroStrategy Incorporated d/b/a Strategy (“Strategy” or the “Company”) (NASDAQ: MSTR) securities between April 30, 2024 and April 4, 2025, inclusive (the “Class Period”). Strategy investors have until July 15, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of MicroStrategy Incorporated d/b/a Strategy (“Strategy” or the “Company”) (NASDAQ: MSTR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming July 11, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) common stock between April 18, 2024, and October 16, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP reminds investors of the upcoming July 15, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT) securities between February 25, 2025 and May 7, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming July 14, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA) securities between May 9, 2024 and May 8, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP reminds investors of the upcoming July 1, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Civitas Resources, Inc. (“Civitas” or the “Company”) (NYSE: CIVI) securities between February 27, 2024 and February 24, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Western District of North Carolina, captioned Cameron v. Krispy Kreme, Inc., et al., Case No. 25-cv-332, on behalf of persons and entities that purchased or otherwise acquired Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT) securities between February 25, 2025 and May 7, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay & Murray LLP reminds investors of the upcoming July 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Digimarc Corporation (“Digimarc” or the “Company”) (NASDAQ: DMRC) securities between May 3, 2024 and February 26, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP reminds investors of the upcoming July 7, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) common stock between April 18, 2024, and October 16, 2024, inclusive (the “Class Period”). Elevance investors have until July 11, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Coinbase Global, Inc. (“Coinbase” or the “Company”) (NASDAQ: COIN) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Farberov v. Iovance Biotherapeutics, Inc., et al., Case No. 25-cv-4199, on behalf of persons and entities that purchased or otherwise acquired Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA) securities between May 9, 2024 and May 8, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay & Murray LLP reminds investors of the upcoming July 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Compass Diversified (“Compass” or the “Company”) (NYSE: CODI) securities between May 1, 2024 and May 7, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Cleveland-Cliffs Inc. (“Cleveland-Cliffs” or the “Company”) (NYSE: CLF) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of EchoStar Corporation (“EchoStar” or the “Company”) (NASDAQ: SATS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”). West investors have until July 7, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Civitas Resources, Inc. (“Civitas” or the “Company”) (NYSE: CIVI) securities between February 27, 2024 and February 24, 2025, inclusive (the “Class Period”). Civitas investors have until July 1, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Digimarc Corporation (“Digimarc” or the “Company”) (NASDAQ: DMRC) securities between May 3, 2024 and February 26, 2025, inclusive (the “Class Period”). Digimarc investors have until July 8, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of EchoStar Corporation (“EchoStar” or the “Company”) (NASDAQ: SATS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Compass Diversified (“Compass” or the “Company”) (NYSE: CODI) securities between May 1, 2024 and May 7, 2025, inclusive (the “Class Period”). Compass investors have until July 8, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ: GOCO) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Compass Diversified (“Compass” or the “Company”) (NYSE: CODI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Ichor Holdings, Ltd. (“Ichor” or the “Company”) (NASDAQ: ICHR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Bausch + Lomb Corporation (“BLCO” or the “Company”) (NYSE: BLCO) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ: MYGN) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Civitas Resources, Inc. (“Civitas” or the “Company”) (NYSE: CIVI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming June 24, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Napco Security Technologies, Inc. (“Napco” or the “Company”) (NASDAQ: NSSC) securities between February 5, 2024, to February 3, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Landstar System, Inc. (“Landstar” or the “Company”) (NASDAQ: LSTR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Compass Diversified (or the “Company”) (NYSE: CODI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Cable One, Inc. (“Cable One” or the “Company”) (NYSE: CABO) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming June 24, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Avis Budget Group, Inc. (“Avis” or the “Company”) (NASDAQ: CAR) securities between February 16, 2024 and February 10, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Napco Security Technologies, Inc. (“Napco” or the “Company”) (NASDAQ: NSSC) securities between February 5, 2024, to February 3, 2025, inclusive (the “Class Period”). Napco investors have until June 24, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming June 30, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Open Lending Corporation (“Open Lending” or the “Company”) (NASDAQ: LPRO) securities between February 24, 2022 and March 31, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Avis Budget Group, Inc. (“Avis” or the “Company”) (NASDAQ: CAR) securities between February 16, 2024 and February 10, 2025, inclusive (the “Class Period”). Avis investors have until June 24, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Kohl's Corporation (“Kohl's” or the “Company”) (NYSE: KSS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Western District of Texas, captioned Bradley v. Open Lending Corporation, et al., Case No. 1:25-cv-00650, on behalf of persons and entities that purchased or otherwise acquired Open Lending Corporation (“Open Lending” or the “Company”) (NASDAQ: LPRO) securities between February 24, 2022 and March 31, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Napco Security Technologies, Inc. (“Napco” or the “Company”) (NASDAQ: NSSC) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Avis Budget Group, Inc. (“Avis” or the “Company”) (NASDAQ: CAR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Landstar System, Inc. (“Landstar” or the “Company”) (NASDAQ: LSTR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming June 16, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Ibotta, Inc. (“Ibotta” or the “Company”) (NYSE: IBTA) securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s April 2024 initial public offering (the “IPO” or “Offering”).

Glancy Prongay & Murray LLP reminds investors of the upcoming June 17, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired NET Power Inc. (“Net Power” or the “Company”) (NYSE: NPWR) securities between June 9, 2023 and March 7, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ: ICUI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired NET Power Inc. (“Net Power” or the “Company”) (NYSE: NPWR) securities between June 9, 2023 and March 7, 2025, inclusive (the “Class Period”). NET Power investors have until June 17, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP reminds investors of the upcoming June 10, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI) securities between May 8, 2023 and May 7, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Uber Technologies, Inc. (“Uber” or the “Company”) (NYSE: UBER) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of TechTarget, Inc. (“TechTarget” or the “Company”) (NASDAQ: TTGT) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Ibotta, Inc. (“Ibotta” or the “Company”) (NYSE: IBTA) securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s April 2024 initial public offering (the “IPO” or “Offering”). Ibotta investors have until June 16, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI) securities between May 8, 2023 and May 7, 2024, inclusive (the “Class Period”). Treace Medical investors have until June 10, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP reminds investors of the upcoming June 3, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Canopy Growth Corporation (“Canopy” or the “Company”) (NASDAQ: CGC) securities between May 30, 2024 and February 6, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Canopy Growth Corporation (“Canopy” or the “Company”) (NASDAQ: CGC) securities between May 30, 2024 and February 6, 2025, inclusive (the “Class Period”). Canopy investors have until June 3, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Movado Group, Inc. (“Movado” or the “Company”) (NYSE: MOV) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of CarMax, Inc. (“CarMax” or the “Company”) (NYSE: KMX) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Canopy Growth Corporation (“Canopy” or the “Company”) (NASDAQ: CGC) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming June 3, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Viatris Inc. (“Viatris” or the “Company”) (NASDAQ: VTRS) securities between August 8, 2024, to February 26, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP reminds investors of the upcoming June 3, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Everus Construction Group, Inc. (“Everus” or the “Company”) (NYSE: ECG) common stock between October 31, 2024 and February 11, 2025, inclusive (the “Class Period”), including investors who held MDU Resources Group, Inc. (“MDU Resources”) common stock as of October 21, 2024 and acquired Everus common stock issued in connection with the spinoff of Everus Construction (defined below) on or about October 31, 2024 (the “Spinoff”).